Stock Quote        
  Join        Login  
logo

Metlife (MET) 2Q Earnings Surge On Derivative Gains

 August 01, 2012 04:36 PM
 

(By Balaseshan) Metlife Inc. (NYSE:MET), the largest life insurer in the United States, reported a surge in quarterly earnings driven by net derivative gains of $1.4 billion.
 
Profit jumped 111.8% to $2.26 billion for the second quarter. Results included derivative gains largely due to decreases in interest rates and the impact of MetLife's credit spreads during the quarter.

Operating earnings per share (EPS) grew 18% to $1.33 from $1.13, reflecting strong growth in all three geographic regions.

Operating revenue rose 0.9% to $16.79 billion. Analysts had expected a profit of $1.25 per share on revenue of $16.98 billion. Premiums, fees & other revenues marginally declined 0.3% to $11.60 billion.

Premiums, fees & other revenues for the Americas were down slightly at $8.4 billion, largely due to a decline in pension closeout sales, which often fluctuate significantly from quarter to quarter.

Premiums, fees & other revenues in Asia increased 6% to $2.3 billion, due to business growth in Japan and Australia. Total sales for the region climbed 14%, driven by increases in Japan, China and Australia.

Premiums, fees & other revenues in Europe, the Middle East and Africa (EMEA) declined 4% $815 million but up 3% on a constant currency basis. Total sales for the region increased 13% despite the challenging economic environment in Europe. Turkey, Russia and the Gulf countries contributed to the sales growth in the quarter.

Net investment income increased 4% to $5.2 billion, driven by solid recurring income, while variable investment income was above the plan range at $371 million, up from $273 million last year.

MET closed Wednesday's regular session down 1.10% at $30.43. The stock has been trading between $25.61 and $40.75 for the past 52 weeks.


Rich
i On The Market - Daily Newsletter
Every trading day, be ready to attack the market instead of reacting to the market.

You will know where the key technical resistance and support levels are and what the market is likely to do next. iStock will arm you with a target list of stocks to buy and sell - right now - based on our exclusive, proprietary trading models.

Two Week FREE Trial


Signup for i on the market daily edition


Advertisement

Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

Advertisement
Connect with iStockAnalyst
Popular Articles
Recent Research and Quote
Advertisement
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.